Medical device for in vitro diagnostics "Reagent for determining prothrombin time by the clotting method (Renamplastin) according to TU 21.20.23-066-05595541-2019 " (abbreviated name – "Renamplastin").
The Renamplastin reagent is designed to determine the prothrombin time (PV) in venous blood plasma and calculate the prothrombin ratio (PO), prothrombin index (PI) and International Normalized Ratio (INR), as well as to determine the prothrombin by Quick in% of the norm.
MICH=1.0-1.3.
The determination of prothrombin time is a highly sensitive screening test that detects abnormalities in the external and general blood coagulation pathway (f. II, V, VII and X) and is recommended for:
monitoring of indirect anticoagulant therapy;
diagnostics of hereditary and acquired coagulopathies;
diagnosis of liver diseases.
The Renamplate set is designed to work on all types of semi-automatic and automatic coagulometers and by manual method.
The principle of the method:
When added to the c
The composition of the sets:
One vial of freeze-dried Renamplastin is designed to carry out 80 determinations at a consumption of 0.1 ml of reagent solution per analysis.
One bottle of liquid Renamplastin is designed to carry out 50 determinations at a consumption of 0.1 ml of reagent solution per analysis.
Normal and pathological values of the studied hemostasis parameters should be monitored using a set of "Control plasmas to control the correctness of INR determination during oral anticoagulant therapy (level 3) (Prothrombin control) according to TU 9398-056-05595541-2015" (catalog number KM-17) or using "Control plasma (pool of healthy donors) (Plasma H) according to TU 9398-004-05595541-2009", (catalog number KM-1).
